Insider · CIK 0001627642

ZACCARDELLI DAVID

Reports to the SEC for 6 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001627642

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-07	VORVor Biopharma Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+42.7K sh	—	—	42,658
2026-01-05	SABSSAB Biotherapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+240K sh	—	—	240,000
2025-10-07	VRNAVerona Pharma plcD Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−12.2M sh	—	—	0
2025-10-07	VRNAVerona Pharma plcM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+3.29M sh	—	—	3,285,280
2025-10-07	VRNAVerona Pharma plcD Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−3.29M sh	—	—	0
2025-10-07	VRNAVerona Pharma plc · Restricted Share UnitM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−800K sh	—	—	0
2025-10-07	VRNAVerona Pharma plc · Restricted Share UnitM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−390K sh	—	—	0
2025-10-07	VRNAVerona Pharma plc · Restricted Share UnitM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−446K sh	—	—	0
2025-10-07	VRNAVerona Pharma plc · Restricted Share UnitA Award	Director, President and CEO	AAward	+1.65M sh	—	—	1,649,952
2025-10-07	VRNAVerona Pharma plc · Restricted Share UnitM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−1.65M sh	—	—	0
2025-08-29	VRNAVerona Pharma plcG Gift	Director, President and CEO	GGift	−1.2M sh	—	—	12,176,144
2025-08-01	VRNAVerona Pharma plcM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+256K sh	—	—	13,585,056
2025-08-01	VRNAVerona Pharma plcS Sale	Director, President and CEO	SSale	−209K sh	$13.14	−$2.75M	13,376,144
2025-08-01	VRNAVerona Pharma plc · Restricted Stock UnitsM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−200K sh	—	—	800,000
2025-08-01	VRNAVerona Pharma plc · Restricted Stock UnitsM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−55.7K sh	—	—	389,792
2025-07-08	VRNAVerona Pharma plcF Tax Payment	Director, President and CEO	FTax Payment	−90.3K sh	$11.44	−$1.03M	13,329,360
2025-07-07	VRNAVerona Pharma plcM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+230K sh	—	—	13,419,680
2025-07-07	VRNAVerona Pharma plc · Restricted Share UnitsA Award	Director, President and CEO	AAward	+675K sh	—	—	675,048
2025-07-07	VRNAVerona Pharma plc · Restricted Share UnitsM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−230K sh	—	—	445,536
2025-06-11	VRNAVerona Pharma plcS Sale	Director, President and CEO	SSale	−400K sh	$11.40	−$4.56M	13,190,168
2025-05-29	VRNAVerona Pharma plcS Sale	Director, President and CEO	SSale	−209K sh	$9.33	−$1.95M	13,590,168
2025-05-28	VRNAVerona Pharma plcS Sale	Director, President and CEO	SSale	−158K sh	$9.30	−$1.47M	13,798,864
2025-05-27	VRNAVerona Pharma plcS Sale	Director, President and CEO	SSale	−33.6K sh	$9.53	−$320K	13,956,568
2025-05-02	VRNAVerona Pharma plcS Sale	Director, President and CEO	SSale	−400K sh	$9.09	−$3.64M	13,990,168
2025-05-01	VRNAVerona Pharma plcS Sale	Director, President and CEO	SSale	−108K sh	$8.95	−$969K	14,268,904
2025-05-01	VRNAVerona Pharma plcM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+200K sh	—	—	14,468,904
2025-05-01	VRNAVerona Pharma plcS Sale	Director, President and CEO	SSale	−78.7K sh	$8.95	−$705K	14,390,168
2025-05-01	VRNAVerona Pharma plc · Restricted Share UnitsM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−200K sh	—	—	1,000,000
2025-04-29	VRNAVerona Pharma plcM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+230K sh	—	—	14,467,536
2025-04-29	VRNAVerona Pharma plcS Sale	Director, President and CEO	SSale	−90.4K sh	$8.98	−$811K	14,377,176
2025-04-29	VRNAVerona Pharma plc · Restricted Share UnitsA Award	Director, President and CEO	AAward	+675K sh	—	—	675,000
2025-04-29	VRNAVerona Pharma plc · Restricted Share UnitsM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−230K sh	—	—	445,488
2025-02-03	VRNAVerona Pharma plcF Tax Payment	Director, President and CEO	FTax Payment	−167K sh	$7.16	−$1.19M	14,238,024
2025-02-01	VRNAVerona Pharma plcA Award	Director, President and CEO	AAward	+200K sh	—	—	14,404,752
2024-12-06	VRNAVerona Pharma plcS Sale	Director, President and CEO	SSale	−163K sh	$5.01	−$815K	14,204,752
2024-12-05	VRNAVerona Pharma plcS Sale	Director, President and CEO	SSale	−640K sh	$5.01	−$3.21M	14,367,552
2024-12-04	VRNAVerona Pharma plcS Sale	Director, President and CEO	SSale	−67.6K sh	$5.00	−$338K	15,007,816
2024-12-02	VRNAVerona Pharma plcS Sale	Director, President and CEO	SSale	−3,200 sh	$5.00	−$16K	15,075,424
2024-11-29	VRNAVerona Pharma plcS Sale	Director, President and CEO	SSale	−98.9K sh	$5.01	−$495K	15,078,624
2024-11-27	VRNAVerona Pharma plcS Sale	Director, President and CEO	SSale	−23.2K sh	$5.00	−$116K	15,177,512
2024-11-25	VRNAVerona Pharma plcS Sale	Director, President and CEO	SSale	−1,600 sh	$5.00	−$8,000	15,200,752
2024-11-11	VRNAVerona Pharma plcS Sale	Director, President and CEO	SSale	−2,400 sh	$5.00	−$12K	15,202,352
2024-11-04	VRNAVerona Pharma plcS Sale	Director, President and CEO	SSale	−94.1K sh	$4.39	−$413K	15,204,752
2024-11-01	VRNAVerona Pharma plcS Sale	Director, President and CEO	SSale	−46.9K sh	$4.38	−$205K	15,298,896
2024-11-01	VRNAVerona Pharma plcA Award	Director, President and CEO	AAward	+200K sh	—	—	15,591,736
2024-11-01	VRNAVerona Pharma plcF Tax Payment	Director, President and CEO	FTax Payment	−246K sh	$4.24	−$1.04M	15,345,784
2024-10-30	VRNAVerona Pharma plcA Award	Director, President and CEO	AAward	+800K sh	—	—	15,391,736
2024-10-25	VRNAVerona Pharma plcS Sale	Director, President and CEO	SSale	−4,800 sh	$4.38	−$21K	14,591,736
2024-10-24	VRNAVerona Pharma plcS Sale	Director, President and CEO	SSale	−140K sh	$4.38	−$613K	14,596,536
2024-10-23	VRNAVerona Pharma plcS Sale	Director, President and CEO	SSale	−16 sh	$4.38	−$70	14,736,536

Recent filings

Accepted (ET)
Jul 94
ZACCARDELLI DAVID0001193125-26-299665
SEC(opens sec.gov)
Jan 74
ZACCARDELLI DAVID0001193125-26-006427
SEC(opens sec.gov)
Oct 84
ZACCARDELLI DAVID0001104659-25-097966
SEC(opens sec.gov)
Sep 34
ZACCARDELLI DAVID0001104659-25-087064
SEC(opens sec.gov)
Aug 54
ZACCARDELLI DAVID0001104659-25-074389
SEC(opens sec.gov)
Jul 94
ZACCARDELLI DAVID0001104659-25-066763
SEC(opens sec.gov)
Jun 134
ZACCARDELLI DAVID0001104659-25-059398
SEC(opens sec.gov)

Companies

Address

500 BOYLSTON STREET, SUITE 1350

BOSTON, MA, 02116